Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management
Status:
Recruiting
Trial end date:
2022-08-15
Target enrollment:
Participant gender:
Summary
When a patient arrives to an emergency department and is found to have an elevated potassium
level in the blood, there is no one standardized treatment, therefore it is not known if one
treatment is superior to other. The purpose of this study is to help determine if a drug
called patiromer (already approved by the FDA) can help lower potassium levels while patients
are in the emergency department.